Navigating the Landscape of Mineralocorticoid Receptor Antagonists Therapy

11 Jul, 2019 ,
Yale Cardiovascular Medicine
Yale Cardiovascular Medicine
11 Jul, 2019 ,

Mineralocortiooid receptor antagonists (MRAs) are still largely underused in clinical practice. Faiez Zannad, MD, PhD, discusses the rationale behind the use of MRAs in heart failure with reduced ejection fraction.The speaker has also discussed the evidence regarding the use of mineralocorticoid and the gaps in the evidence as well as unmet needs.